SciELO - Scientific Electronic Library Online

 
vol.43 issue2Mortality due to visceral leishmaniasis: clinical and laboratory characteristicsOccurrence of Cryptococcus neoformans in pigeon excrement in the city of Pelotas, State of Rio Grande do Sul author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista da Sociedade Brasileira de Medicina Tropical

Print version ISSN 0037-8682

Abstract

ALVARENGA, Daniel Gomes de; ESCALDA, Patrícia Maria Fonseca; COSTA, Alexandre Sylvio Vieira da  and  MONREAL, Maria Tereza Ferreira Duenhas. Visceral leishmaniasis: retrospective study on factors associated with lethality. Rev. Soc. Bras. Med. Trop. [online]. 2010, vol.43, n.2, pp.194-197. ISSN 0037-8682.  https://doi.org/10.1590/S0037-86822010000200017.

INTRODUCTION: Visceral leishmaniasis is a public health problem, with lethality reaching 10%. The recommended drug treatment is methylglucamine antimoniate. This study aimed to evaluate drug use for cases of visceral leishmaniasis treated at the Infectology Clinic of the Campo Grande University Hospital Center, State of Mato Grosso do Sul. METHODS: To collect data, we examined the medical records of 76 patients with a diagnosis of visceral leishmaniasis treated at this Infectology Clinic. RESULTS: The medical files of 76 patients (56 men and 20 women; 28.9%) showed comorbidities. The first choice drug for 88.2% of the patients was N-methylglucamine antimoniate, with a fatal outcome for 18.4%. Survival analysis showed a statistically significant difference between patients with and without comorbidities (p <0.0001) and with comorbidities who used Glucantime® (p < 0.0009). The fatality rate of 18.4% indicates the low efficiency of the healthcare measures used. CONCLUSIONS: The results suggest that the prognosis becomes poor when associated with the presence of comorbidities, and that the treatment needs to be carefully administered to minimize mortality.

Keywords : Visceral leishmaniasis; Drug use; Retrospective study; Survival analysis.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License